COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal (TAPER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04070157
Recruitment Status : Suspended (Enrollment on Hold (COVID-19))
First Posted : August 28, 2019
Last Update Posted : August 11, 2020
Information provided by (Responsible Party):
US WorldMeds LLC

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 1, 2021
Estimated Study Completion Date : December 1, 2021